(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KEMPHARM INC

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLED SEC. 8 (6-YR)Type: CombinedOffice: United States

Quick snapshot

KEMPHARM INC

ST13

US500000087980838

Class

42

Filing

87980838

Registration

5962391

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLED SEC. 8 (6-YR)

Case type

Application and registration

Recorded events

46

Latest update

08/18/2026

Trademark type

Combined

Nice classes

42

Filing date

02/15/2018

Registration date

01/14/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/24/2026

Last transaction

08/18/2026

Responsible office

United States Patent and Trademark Office

Status code

710

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/04/2009

First use in commerce

05/04/2009

Drawing code

5

Owner type

03

Owner location

CELEBRATION, FL, US

Examiner

O'ROURKE, JONATHAN RYAN

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized word "KEMPHARM" with the word "INC" above the second "M" in "KEMPHARM" where the "KEM" is in orange and the "PHARM" and "INC" are in blue.

Holders and representatives

Holders

ZEVRA THERAPEUTICS, INC.
KemPharm, Inc.
KemPharm, Inc.

Representatives

Haverly MacArthur Adams and Reese LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Drug discovery services; Medical research; Research and development in the field of drug discovery

Publications

History of USPTO decisions and trademark events.

46 publications found

C8..

CANCELLED SEC. 8 (6-YR)

07/24/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/14/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/06/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/06/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/06/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/22/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

01/14/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/10/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/19/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/22/2019

GNRT

NON-FINAL ACTION E-MAILED

05/22/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/22/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/09/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/08/2019

DPCC

DIVISIONAL PROCESSING COMPLETE

05/08/2019

EX1G

SOU EXTENSION 1 GRANTED

05/08/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/30/2019

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/30/2019

IROA

RESPONSE TO ITU OFFICE ACTION ENTERED

04/17/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/17/2019

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

04/17/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/09/2019

IUAF

USE AMENDMENT FILED

03/18/2019

DRRR

DIVISIONAL REQUEST RECEIVED

03/18/2019

EXT1

SOU EXTENSION 1 FILED

03/18/2019

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

03/18/2019

EEXT

SOU TEAS EXTENSION RECEIVED

03/18/2019

EISU

TEAS STATEMENT OF USE RECEIVED

03/18/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/18/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/24/2018

PUBO

PUBLISHED FOR OPPOSITION

07/24/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/04/2018

ALIE

ASSIGNED TO LIE

06/15/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/01/2018

XAEC

EXAMINER'S AMENDMENT ENTERED

06/01/2018

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/01/2018

GNEA

EXAMINERS AMENDMENT E-MAILED

06/01/2018

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/01/2018

DOCK

ASSIGNED TO EXAMINER

05/31/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/23/2018

NWAP

NEW APPLICATION ENTERED

02/19/2018

Continuous trademark protection

Get notified about every new filing that threatens KEMPHARM INC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.